Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for Myopia Progression in Children and Adolescents (MODERATO)
NCT07028827Phase 3Recruiting
- Sponsor
- OCUS Innovation
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 5
01
Overview
A Phase 3 trial of NVK002 in myopia, sponsored by OCUS Innovation. Started Sep 2025; status: recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07028827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07028827.